Food and Drug Administration, U.S. Department of Health and Human Services - December 23, 1992
Monica Revelle - (301) 443-4177
FDA has received inquiries about the recent approval of dronabinol for the treatment of anorexia associated with weight loss in patients with AIDS. The following can be used to answer questions. Dronabinol is a synthetic form of delta-9-tetrahydrocannabinol (THC), an active ingredient in marijuana that
Food and Drug Administration, U.S. Department of Health and Human Services - December 23, 1992
Monica Revelle - (301) 443-4177
The Food and Drug Administration today announced the approval of rifabutin, a drug to prevent Mycobacterium avium complex ( MAC ) disease in people with advanced HIV infection. Rifabutin is the first drug approved for the prevention of MAC disease. Individuals with MAC infection experience chronic debilitating symptoms
Food and Drug Administration, U.S. Department of Health and Human Services - December 8, 1992
Monica Revelle - (301) 443-4177
The Food and Drug Administration today announced that it will soon publish new rules to speed the approval of drugs for patients with serious or life-threatening illnesses, such as AIDS, cancer and Alzheimer s disease. These final rules will help patients who are suffering the most serious illnesses to get access to ne
Food and Drug Administration, U.S. Department of Health and Human Services - November 16, 1992
Monica Revelle - (301) 443-4177
The U.S. Public Health Service today advised women that frequent or persistent cases of vaginal fungal infections known as yeast infections or vaginal candidiasis may sometimes be an early warning of HIV infection. HHS Assistant Secretary for Health James Mason, M.D., who heads the Public Health Service, said most of t
Food and Drug Administration, U.S. Department of Health and Human Services - October 26, 1992
Sharon Snider, (301) 443-3285
Federal government scientists, medical professionals and industry representatives will meet Nov. 5-7 in Baltimore, Md., to discuss allergic reactions to latex medical devices. International Latex Conference: Sensitivity to Latex in Medical Devices, sponsored by the Food and Drug Administration, the Centers for Disease
Food and Drug Administration, U.S. Department of Health and Human Services - June 22, 1992
Faye Peterson - (301) 443-3285
HHS Secretary Louis W. Sullivan, M.D., today announced that the Food and Drug Administration has approved the AIDS drug zalcitabine, commonly known as ddC . It is the third drug licensed specifically for use in treating the human immunodeficiency virus, the cause of AIDS.
Food and Drug Administration, U.S. Department of Health and Human Services - January 30, 1992
Brad Stone -- (301)443-3285
The Food and Drug Administration announced today it has issued an import alert against unapproved mail-order drugs promoted by six overseas companies. Many of these drugs are illegally advertised in periodicals and through direct mail, as foreign versions of approved prescription drugs. The promotion and distribution o